{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:27:00Z","timestamp":1789504020695,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,9]],"date-time":"2025-03-09T00:00:00Z","timestamp":1741478400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014331","name":"Motor Neurone Disease Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022513","name":"Tasmanian Department of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022513","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Genetics & Development"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.gde.2025.102343","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T11:17:37Z","timestamp":1743419857000},"page":"102343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["To splice or not to splice: pseudoexons in neurological disease and opportunities for intervention"],"prefix":"10.1016","volume":"92","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8632-641X","authenticated-orcid":false,"given":"Sue","family":"Fletcher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9475-103X","authenticated-orcid":false,"given":"Niall P","family":"Keegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2249-1253","authenticated-orcid":false,"given":"Rita","family":"Mejzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ianthe L","family":"Pitout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gde.2025.102343_bib1","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1080\/15476286.2020.1809195","article-title":"In silico identification of pseudo-exon activation events in personal genome and transcriptome data","volume":"18","author":"Sakaguchi","year":"2021","journal-title":"RNA Biol"},{"key":"10.1016\/j.gde.2025.102343_bib2","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-022-01026-w","article-title":"A guide for the diagnosis of rare and undiagnosed disease: beyond the exome","volume":"14","author":"Marwaha","year":"2022","journal-title":"Genome Med"},{"key":"10.1016\/j.gde.2025.102343_bib3","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/s41594-022-00844-1","article-title":"Mechanism and modeling of human disease-associated near-exon intronic variants that perturb RNA splicing","volume":"29","author":"Chiang","year":"2022","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.gde.2025.102343_sbref4","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1093\/nar\/gkae077","article-title":"All exons are not created equal-exon vulnerability determines the effect of exonic mutations on splicing","volume":"52","author":"Holm","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.gde.2025.102343_sbref5","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/humu.24306","article-title":"Pseudoexon activation in disease by non-splice site deep intronic sequence variation - wild type pseudoexons constitute high-risk sites in the human genome","volume":"43","author":"Petersen","year":"2022","journal-title":"Hum Mutat"},{"key":"10.1016\/j.gde.2025.102343_bib6","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/j.1742-4658.2009.07520.x","article-title":"Alternative splicing: role of pseudoexons in human disease and potential therapeutic strategies","volume":"277","author":"Dhir","year":"2010","journal-title":"FEBS J"},{"key":"10.1016\/j.gde.2025.102343_bib7","article-title":"The spectrum of pre-mRNA splicing in autism","volume":"15","author":"Engal","year":"2024","journal-title":"Wiley Inter Rev RNA"},{"key":"10.1016\/j.gde.2025.102343_sbref8","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.tig.2023.04.008","article-title":"Pre-mRNA splicing and its cotranscriptional connections","volume":"39","author":"Shenasa","year":"2023","journal-title":"Trends Genet"},{"key":"10.1016\/j.gde.2025.102343_bib9","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s13353-018-0444-7","article-title":"Splicing mutations in human genetic disorders: examples, detection, and confirmation","volume":"59","author":"Anna","year":"2018","journal-title":"J Appl Genet"},{"key":"10.1016\/j.gde.2025.102343_bib10","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/humu.20493","article-title":"Extensive in silico analysis of NF1 splicing defects uncovers determinants for splicing outcome upon 5\u2032 splice-site disruption","volume":"28","author":"Wimmer","year":"2007","journal-title":"Hum Mutat"},{"key":"10.1016\/j.gde.2025.102343_bib11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrg.2015.3","article-title":"RNA mis-splicing in disease","volume":"17","author":"Scotti","year":"2016","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.gde.2025.102343_bib12","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.gde.2020.05.030","article-title":"Poison exons in neurodevelopment and disease","volume":"65","author":"Carvill","year":"2020","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.gde.2025.102343_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.657040","article-title":"Novel intronic mutations introduce pseudoexons in DMD that cause muscular dystrophy in patients","volume":"12","author":"Lu","year":"2021","journal-title":"Front Genet"},{"key":"10.1016\/j.gde.2025.102343_bib14","article-title":"A novel deep intronic variant introduce dystrophin pseudoexon in Becker muscular dystrophy: a case report","volume":"10","author":"Liu","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.gde.2025.102343_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2024.148862","article-title":"A novel deep intronic variant in the DMD gene causes Duchenne muscular dystrophy by pseudoexon activation encoding a nonsense codon","volume":"930","author":"Foncuberta","year":"2024","journal-title":"Gene"},{"key":"10.1016\/j.gde.2025.102343_bib16","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.nmd.2020.06.003","article-title":"Rare intronic mutation between Exon 62 and 63 (c.9225-285A>G) of the dystrophin gene associated with atypical BMD phenotype","volume":"30","author":"Schussler","year":"2020","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.gde.2025.102343_bib17","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/humu.23920","article-title":"Deep-intronic variants in CNGB3 cause achromatopsia by pseudoexon activation","volume":"41","author":"Weisschuh","year":"2020","journal-title":"Hum Mutat"},{"key":"10.1016\/j.gde.2025.102343_bib18","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ajhg.2018.02.008","article-title":"Identification and rescue of splice defects caused by two neighboring deep-intronic ABCA4 mutations underlying stargardt disease","volume":"102","author":"Albert","year":"2018","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.gde.2025.102343_bib19","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1534\/genetics.104.039701","article-title":"Subdivision of large introns in Drosophila by recursive splicing at nonexonic elements","volume":"170","author":"Burnette","year":"2005","journal-title":"Genetics"},{"key":"10.1016\/j.gde.2025.102343_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1007579","article-title":"The temporal landscape of recursive splicing during Pol II transcription elongation in human cells","volume":"14","author":"Zhang","year":"2018","journal-title":"PLoS Genet"},{"key":"10.1016\/j.gde.2025.102343_bib21","article-title":"Analysis of pathogenic pseudoexons reveals novel mechanisms driving cryptic splicing","volume":"12","author":"Keegan","year":"2021","journal-title":"Front Genet"},{"key":"10.1016\/j.gde.2025.102343_bib22","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.molcel.2018.09.033","article-title":"Exon junction complex shapes the transcriptome by repressing recursive splicing","volume":"72","author":"Blazquez","year":"2018","journal-title":"Mol Cell"},{"key":"10.1016\/j.gde.2025.102343_sbref23","doi-asserted-by":"crossref","DOI":"10.1093\/gigascience\/giad085","article-title":"Computational prediction of human deep intronic variation","volume":"12","author":"Barbosa","year":"2022","journal-title":"Gigascience"},{"key":"10.1016\/j.gde.2025.102343_bib24","article-title":"A spotter's guide to SNPtic exons: the common splice variants underlying some SNP-phenotype correlations","volume":"10","author":"Keegan","year":"2022","journal-title":"Mol Genet Genom Med"},{"key":"10.1016\/j.gde.2025.102343_bib25","article-title":"Genomewide paired DNA-RNAseq analyses to discover intronic splice mutation hotspots in neurological disorders","author":"Wang","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.gde.2025.102343_sbref26","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.ajhg.2024.03.007","article-title":"The clinical utility and diagnostic implementation of human subject cell transdifferentiation followed by RNA sequencing","volume":"111","author":"Li","year":"2024","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.gde.2025.102343_bib27","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2314225120","article-title":"Genome-wide detection of human intronic AG-gain variants located between splicing branchpoints and canonical splice acceptor sites","volume":"120","author":"Zhang","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.gde.2025.102343_bib28","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s12272-023-01450-5","article-title":"Harnessing deep learning into hidden mutations of neurological disorders for therapeutic challenges","volume":"46","author":"Yang","year":"2023","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.gde.2025.102343_bib29","doi-asserted-by":"crossref","DOI":"10.1186\/s12864-023-09645-2","article-title":"PDIVAS: pathogenicity predictor for deep-intronic variants causing aberrant splicing","volume":"24","author":"Kurosawa","year":"2023","journal-title":"BMC Genom"},{"key":"10.1016\/j.gde.2025.102343_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-56704-z","article-title":"Successful skipping of abnormal pseudoexon by antisense oligonucleotides in vitro for a patient with beta-propeller protein-associated neurodegeneration","volume":"14","author":"Yamada","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.gde.2025.102343_sbref31","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2023.102101","article-title":"Regulating PCCA gene expression by modulation of pseudoexon splicing patterns to rescue enzyme activity in propionic acidemia","volume":"35","author":"Spangsberg Petersen","year":"2024","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.gde.2025.102343_bib32","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1097\/TP.0000000000003501","article-title":"Liver transplantation for propionic acidemia: evidence from a systematic review and meta-analysis","volume":"105","author":"Zhou","year":"2021","journal-title":"Transplantation"},{"key":"10.1016\/j.gde.2025.102343_bib33","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1089\/nat.2021.0066","article-title":"Antisense oligonucleotide rescue of deep-intronic variants activating pseudoexons in the 6-pyruvoyl-tetrahydropterin synthase gene","volume":"32","author":"Martinez-Pizarro","year":"2022","journal-title":"Nucleic Acid Ther"},{"key":"10.1016\/j.gde.2025.102343_bib34","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/hae.14134","article-title":"Identification of new F8 deep intronic variations in patients with haemophilia A","volume":"26","author":"Dericquebourg","year":"2020","journal-title":"Haemophilia"},{"key":"10.1016\/j.gde.2025.102343_sbref35","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2302534120","article-title":"Antisense oligonucleotide rescue of CGG expansion-dependent FMR1 mis-splicing in fragile X syndrome restores FMRP","volume":"120","author":"Shah","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.gde.2025.102343_bib36","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz6100","article-title":"Antisense oligonucleotides increase Scn1a expression and reduce seizures and SUDEP incidence in a mouse model of Dravet syndrome","volume":"12","author":"Han","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.gde.2025.102343_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1528-1167.2011.02993.x","article-title":"Severe myoclonic epilepsy in infancy (Dravet syndrome) 30 years later","volume":"52","author":"Dravet","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.gde.2025.102343_bib38","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/15357597221106281","article-title":"Dravet syndrome as an example of precision medicine in epilepsy","volume":"23","author":"Sullivan","year":"2023","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.gde.2025.102343_bib39","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-023-00646-z","article-title":"TDP-43-regulated cryptic RNAs accumulate in Alzheimer's disease brains","volume":"18","author":"Estades Ayuso","year":"2023","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.gde.2025.102343_bib40","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-023-00608-5","article-title":"The era of cryptic exons: implications for ALS-FTD","volume":"18","author":"Mehta","year":"2023","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.gde.2025.102343_bib41","doi-asserted-by":"crossref","DOI":"10.1007\/s00401-023-02655-0","article-title":"Cryptic splicing of stathmin-2 and UNC13A mRNAs is a pathological hallmark of TDP-43-associated Alzheimer's disease","volume":"147","author":"Agra Almeida Quadros","year":"2024","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.gde.2025.102343_bib42","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41586-022-04424-7","article-title":"TDP-43 represses cryptic exon inclusion in the FTD-ALS gene UNC13A","volume":"603","author":"Ma","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.gde.2025.102343_bib43","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41586-022-04436-3","article-title":"TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A","volume":"603","author":"Brown","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.gde.2025.102343_bib44","article-title":"Loss of TDP-43 induces synaptic dysfunction that is rescued by UNC13A splice-switching ASOs","author":"Keuss","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.gde.2025.102343_bib45","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124403","article-title":"A recurrent COL6A1 pseudoexon insertion causes muscular dystrophy and is effectively targeted by splice-correction therapies","volume":"4","author":"Bolduc","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.gde.2025.102343_sbref46","doi-asserted-by":"crossref","DOI":"10.1038\/s41525-021-00277-7","article-title":"Oligonucleotide correction of an intronic TIMMDC1 variant in cells of patients with severe neurodegenerative disorder","volume":"7","author":"Kumar","year":"2022","journal-title":"NPJ Genom Med"},{"key":"10.1016\/j.gde.2025.102343_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28227631","article-title":"Research progress on natural plant molecules in regulating the blood-brain barrier in Alzheimer's disease","volume":"28","author":"Wu","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.gde.2025.102343_bib48","doi-asserted-by":"crossref","DOI":"10.1186\/s12987-020-00230-3","article-title":"A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity","volume":"17","author":"Kadry","year":"2020","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.gde.2025.102343_bib49","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.129240","article-title":"Brain pharmacology of intrathecal antisense oligonucleotides revealed through multimodal imaging","volume":"4","author":"Mazur","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.gde.2025.102343_bib50","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cell.2021.10.029","article-title":"Central nervous system regeneration","volume":"185","author":"Varadarajan","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.gde.2025.102343_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/genes15070821","article-title":"Preparing for patient-customized N-of-1 antisense oligonucleotide therapy to treat rare diseases","volume":"15","author":"Wilton-Clark","year":"2024","journal-title":"Genes"}],"container-title":["Current Opinion in Genetics & Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959437X25000358?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959437X25000358?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T04:21:30Z","timestamp":1778300490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959437X25000358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":51,"alternative-id":["S0959437X25000358"],"URL":"https:\/\/doi.org\/10.1016\/j.gde.2025.102343","relation":{},"ISSN":["0959-437X"],"issn-type":[{"value":"0959-437X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"To splice or not to splice: pseudoexons in neurological disease and opportunities for intervention","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Genetics & Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gde.2025.102343","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102343"}}